VReal Affordable neurological telerehabilitation

  • Edition: 2018
  • Research center: Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
  • Scientific Area: Clinical sciences
  • Business area: Therapeutic
  • Status: In development
  • Contact: quicohg87@hotmail.com

VReal is an affordable telerehabilitation platform that helps patients with neurological deficits, such as those caused by a stroke, to regain their independence. Using the patient’s smartphone, the platform provides evidence-based, cost-effective neurological telerehabilitation through a range of 360-degree virtual reality (VR) videos. VReal combines three different treatments: Mirror Therapy, Action Observation, and Motor Imagery, which were traditionally used separately. VReal patients will also benefit from the synergistic effect of this approach.

Goals

  • To meet the entirety of patients’ rehabilitation needs through VR, placing them just one virtual step away from high-quality evidence-based therapy.

Problem to Solve

Every six seconds, someone's quality of life will be changed forever by a stroke. Right now, at least 33 million people worldwide are living with the consequences of brain damage, and studies predict that this number will increase considerably over the next two decades.

Rehabilitation is one of the most important phases of recovery for many stroke survivors. Despite this, the vast majority of patients do not receive adequate treatment in terms of duration, frequency and how specific they are, since they are limited by financial or geographical constraints, among other factors.

Innovation

VReal is a unified, multidimensional, affordable, efficient business-to-consumer (B2C) platform that offers neurorehabilitation therapy. Thanks to Google Cardboard, implantation costs have been eliminated. Moreover, therapies were designed from the ground up, which means they do not require direct supervision from a specialist. This translates to a revolution in terms of the therapy itself (the patient decides where, when and how).

Level of Innovation

VReal already has a prototype version for rehabilitation for patients that have suffered a stroke. A pilot clinical trial has proved that the treatment is safe (no side effects were detected), attractive (96% of users wanted to include it in their daily rehabilitation schedule), fit for the task, immersive and effective.

Team

Project leader

Ezequiel Hidalgo

Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal

Head of Innovation Unit

Diego Velasco

Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal

Head of Rehabilitation Service

Blanca Palomino

Hospital Ramón y Cajal

Head of musculoskeletal section

Belén Alonso

Hospital Ramón y Cajal

Associate Cclinical rehabilitation specialist

María Elena Martínez

Hospital Ramón y Cajal

Mentor

Founder & CSO

Tamara Maes

Oryzon Genomics

Partners

Obra social “la Caixa”
Caixa Capital Risc